- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Endocrinology
Volume 2014 (2014), Article ID 134575, 10 pages
Honokiol Protected against Heatstroke-Induced Oxidative Stress and Inflammation in Diabetic Rats
1Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 112, Taiwan
2Division of Cardiovascular Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei 112, Taiwan
3Nursing Department, Cheng Kung University Hospital, Tainan 701, Taiwan
4Department of Nursing, Chang Jung Christian University, Tainan 712, Taiwan
5Department of Medical Research, Chi Mei Medical Center, Tainan 710, Taiwan
6Department of Surgery, Chi Mei Medical Center, Tainan 710, Taiwan
7Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan 712, Taiwan
Received 17 September 2013; Revised 22 November 2013; Accepted 1 January 2014; Published 17 February 2014
Academic Editor: Ashutosh Kumar
Copyright © 2014 Chuan-Chih Hsu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We aimed at investigating the effect of honokiol on heatstroke in an experimental rat model. Sprogue-Dawley rats were divided into 3 groups: normothermic diabetic rats treated with vehicle solution (NTDR+V), heatstroke-diabetic rats treated with vehicle (HSDR+V), and heatstroke rats treated with konokiol (0.5–5 mg/ml/kg) (HSDR+H). Sixty minutes before the start of heat stress, honokiol or vehicle solution was administered. (HSDR+H) significantly (a) attenuated hyperthermia, hypotension and hypothalamic ischemia, hypoxia, and neuronal apoptosis; (b) reduced the plasma index of the toxic oxidizing radicals; (c) diminished the indices of hepatic and renal dysfunction; (d) attenuated the plasma systemic inflammatory response molecules; (e) promoted plasma levels of an anti-inflammatory cytokine; (f) reduced the index of infiltration of polymorphonuclear neutrophils in the serum; and (g) promoted the survival time fourfold compared with the (HSDR+V) group. In conclusion, honokiol protected against the outcome of heatstroke by reducing inflammation and oxidative stress-mediated multiple organ dysfunction in diabetic rats.
Among the patients with heatstroke at the Mecca Pilgrimage, most of them had diabetes with hyperglycemia . Indeed, compared with nondiabetic rats, diabetic rats were more susceptible to heat stroke occurrence [2, 3]. Most of the heatstroke manifestations (e.g., excessive hyperthermia associated with a systemic inflammatory response that led to multiple organ dysfunction in which the brain dysfunctions predominated) could be reproduced by exposing the streptozotocin-induced diabetic rats to hot environments . The heatstroke-diabetic rats (HSDR) displayed excessive hyperthermia, brain inflammation, ischemia and oxidative damage, and multiple organ dysfunction or failure.
Honokiol was one of main constituents of the Chinese herb, Magnolia officinalis, and had a variety of pharmacological actions, including anti-inflammatory effects , antimicrobial activity [6, 7], and antioxidative effects . However, it was not known whether hypothalamic ischemia and oxidative stress with systemic inflammation and multiple organ dysfunction in HSDR could be affected by honokiol.
Heatstroke was a form of hyperthermia associated with a systemic inflammatory response that led to multiple organ dysfunction, in which central nervous system (CNS) disorders predominated . Based on triad of factors (hyperthermia, CNS disorders, and a history of heat stress), anesthetized rodents all displayed a uniform response which was similar to responses of humans with heatstroke .
The present study was to assess the effects of heat stress on body core temperature (), mean arterial pressure (MAP), hypothalamic values of cerebral blood flow (CBF), partial pressure of O2 (PO2), cellular ischemia marker (e.g., glutamate), organ damage markers (e.g., glycerol and lactate dehydrogenase), toxic oxidizing radicals (e.g., nitric oxide and dihydroxybenzoic acid), and serum levels of inflammatory markers (e.g., interleukin-1β, interleukin-6, tumor necrosis factor-α, and myeloperoxidase) in HSDR with or without honokiol pretreatment.
Adult male Sprague-Dawley rats (weighing 223 to 256 g) were obtained from the Animal Resource Center of the National Science Council of the Republic of China (Taipei, Taiwan). The animals which were allowed to become acclimated for at least one week were housed four per cage at an ambient temperature () of °C with a 12-h light/dark cycle and were supplied with rat chow and tap water ad libitum. The experimental protocol was approved by the Animal Ethic Committee of the Chi Mei Medical Center (Tainan, Taiwan) under guidelines of the National Science Council. Animal care and experiments were according to the Guide for the Care and Use of Laboratory Animals published by the USA National Institutes of Health (NIH publication number 85-23 revised 1996). Adequate anesthesia was maintained to abolish the corneal reflex and pain reflexes induced by tail pinching throughout all experiments (approximately 480 minutes in duration) by a single intraperitoneal dose of urethane (1.4 g/kg body weight). At the end of the experiments, control rats and all rats that had survived heat stroke were sacrificed with an overdose of urethane.
2.2. Surgery and Physiological Parameter Monitoring
The right femoral artery and vein of rats under urethane anesthesia were cannulated with polyethylene tubing (PE50), for blood pressure monitoring and drug administration. The temperature () was monitored continuously by means of a thermocouple, while MAP was monitored continuously with a pressure transducer.
2.3. Induction of Diabetes
Diabetes was induced by injecting streptozotocin (Sigma, St. Louis, MO, USA) at 30 mg/mL/kg of body weight in the tail veins of unanesthetized rats. The animals were maintained for 4-5 weeks before heat stress was applied. At the day of thermal experiments, the right femoral artery and vein of rats under general anesthesia were cannulated with polyethylene tubing (PE50) for blood pressure monitoring and drug administration or biochemical determination, respectively.
2.4. Introduction of Heatstroke
In the present study, the core temperature (at about 37°C) of the anesthetized animals was maintained with an infrared light lamp except in the heat stress experiments. Heatstroke was induced by putting the animals in a bold heating pad of 43°C controlled by circulating hot water. The instant in which MAP dropped to ~50 mmHg was found to be about 60 minutes after the start of heat stress (Figure 1). At 60 minutes, the heating was removed and the animals were allowed to recover at room temperature (26°C). Survival time values (interval between the start of heat stress and animal death) were determined. It was seen in Figure 1 that the heated rats displayed both hyperthermia (~42.5°C) and hypotension (~50 mmHg) at 60 minutes, suggesting the occurrence of heatstroke .
2.5. Experimental Groups
Animals were assigned randomly to one of the following three major groups: normothermic diabetic rats treated with vehicle solution (NTDR + V), heatstroke-diabetic rats treated with vehicle solution (HSDR + V), and heatstroke-diabetic rate treated with honokiol (HSDR + H). Sixty minutes before the start of heat stress, honokiol (H8C2O2) (0.5 mg, 1.5 mg, or 5.0 mg per mL per kg of body weight; Sigma-Aldrich, Saint Louis, MO, USA) or vehicle (DMSO) solution (1 mL per kg body weight) was administered via the veins.
2.6. Measurement of Cerebral Blood Flow (CBF) and Partial Pressure of Oxygen (PO2) in the Hypothalamus
A 100 μm diameter thermocouple and two 230 μm fibers were attached to the oxygen probe. This combined probe measured oxygen, temperature, and microvascular blood flow. The measurement required OxyLite and OxyFlow instruments. OxyLite 2000 (Oxford Optronix Ltd., Oxford, UK) was a 2-channel device (measuring PO2 and temperature at two sites simultaneously), whereas OxyFlo 2000 was a 2-channel Laser Doppler perfusion monitoring instrument. This combined probe was implanted stereotaxically into the right hypothalamus according to the stereotaxic coordinates of Paxinos and Watson  to measure both CBF and PO2 in the hypothalamus.
2.7. Determination of Serum Levels of the Toxic Oxidizing Radicals
For determination of and DHBA, blood samples were taken 0 and 60 minutes after the start of heat exposure. The concentrations in the dialysates were measured with the Eicomo-20 analysis system (Eicom, Kyoto) . The concentrations of hydroxyl radicals were measured by a modified procedure based on the hydroxylation of sodium salicylates by hydroxyl radicals, leading to the production of 2,3-DHBA and 2,5-DHBA .
2.8. Quantification of Organ Function and Injury
For determination of creatinine, blood urea nitrogen (BUN), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) were estimated in blood samples collected at 0 and 60 minutes after the start of heat stress. The serum levels of creatinine, BUN, ALT, AST, and ALP were determined by spectrophotometry (HITACHI7600, Tokyo, Japan). In addition, LDH was measured to evaluate the extent of organ injury by Fuji DRI-CHEM 3030 (Fuji Photo Film Co., Ltd., Tokyo, Japan).
2.9. Measurement of Serum IL-1β, IL-6, TNF-α, IL-10, and ICAM-1 Levels
Blood samples were collected 0 and 60 minutes after the start of heat stress and stored at −80°C until they could be assayed. We used commercially available ELISA kits for the determination of serum IL-1β, IL-6, TNF-α, IL-10, and ICAM-1 levels (Quantikine, R&D Systems Inc., Minneapolis, MN, USA) according to the manufacturer’s instruction.
2.10. Measurement of E-Selectin
Peripheral polymorphonuclear (PMN) cells were isolated from the whole blood of rats and treated with heparin (100 units/mL). Erythrocytes were allowed to sediment for 30 minutes after the addition of 3 mL of 6% dextran (weight/volume in PBS) to 10 mL blood. After sedimentation, the plasma containing leukocytes was centrifuged twice at 300 g for 5 min each. The precipitates were mixed with 70% osmolality-adjusted Percoll and centrifuged at 30,000 g for 30 min at 26°C. The PMN-riched layer was fractionated. Each fraction was washed twice with Hanks’ balanced salt solution, and the cell number was counted. The purity of the PMNS was determined to exceed 95% by Giemsa Staining Cells (1 × 106 cells/tube) which were incubated with a rabbit polyclonal antibody to (CD62E (ab18981; Abcam PIC332, Cambridge, UK) or control. After washing, the cells were stained with a secondary antibody (goat polyclonal to rabbit IgG-H & L [FITC] • [ab6717]; Abcam PIC). Cells were incubated for 1 hour at 4°C and washed. They were mixed with oligasaccharides and incubated for 20 minutes, and then coincubated with KM93 for 60 minutes. The fluorescence intensity of cells was analyzed with a FACStar (Becton Dickinson).
2.11. Determination of Myeloperoxidase (MPO) Activity
A spectrophotometric method  was used to determine MPO activity in the serum. A 100 μL aliquot of serum was mixed with 900 μL of 50 mmol/L phosphate buffer (pH-6.0) containing 0.167 mg/mL of o-dianisidine dihydrochloride and 0.0005% hydrogen peroxide. One unit of peroxidase activity equaled the amount of enzyme decomposing 1 μmol of hydrogen peroxide which was calculated from the oxidation of o-dianisidine using an absorption coefficient of 11.3/mM/cm at 460 nm.
2.12. Assessment of Plasma Corticosterone and ACTH
Plasma corticosterone and ACTH were assayed using Corticosterone Double Antibody RIA kit (MP Biomedicals, Solon, Oh, USA) and ACTH (Rat, Mouse)-RIA kit (Phoenix Pharmaceuticals, Burlingame, CA, USA), respectively. All analyses were performed according to manufacturer’s instruction.
2.13. Statistical Analysis
All data were expressed as means ± standard deviation. One-way analysis of variance with Tukey’s multiple comparisons test was used for serum markers and physiological parameters. Significant differences were established at . For all statistical analyses, SPSS soft ware version 10.0 (SPSS Inc., Chicago, IL, USA) was used.
Diabetic rats had smaller body weight, higher plasma glucose levels, and lower plasma insulin when compared to healthy rats (Table 1).
The survival time values for (HSDR + V) rats were decreased from the (NTDR + V) control values of min to new values of min after the start of heat stress (Table 2). Heatstroke-diabetic rats (HSDR) treated with H (0.5, 1.5, and 5.0 mg/mL/kg of honokiol) 60 minutes before heat stress had significantly and dose-dependently higher values of survival time (114–273 min) than those treated with vehicle. However, in the following experiments, only the effects of one dose of 1.5 mg/mL/kg of honokiol were on determining other parameters during heatstroke.
Figure 1 showed the effects of heat exposure (43°C for 60 minutes) on both and MAP in (NTDR + V) rats, (HSDR + V) rats, and (HSDR + H) rats. As shown in this figure, sixty minutes after the start of heat exposure, the values of MAP in the (HSDR + V) group were significantly lower than those in the (NTDR + V) group (~51 mmHg versus ~92 mmHg; ). On the other hand, the values of in the (HSDR + V) group were significantly higher than those in the (NTDR + V) group (~42.2°C versus ~37.3°C; ). Heat-induced hypotension and hyperthermia were all significantly reduced by honokiol pretreatment as shown in (HSDR + H) group.
Figure 2 showed that the hypothalamic levels of PO2 and cerebral blood flow in the (HSDR + V) rats were significantly lower at 60 minutes after the start of heat exposure than in the (NTDR + V) group (~100 BPU versus ~400 BPU for CBF; ~5 mmHg versus ~20 mmHg for PO2; ). In contrast, the hypothalamic levels of glutamate and glycerol in the (HSDR + V) rats were significantly higher at 60 minutes after the start of heat exposure (~82 mmol/L versus ~3 mmHg for glutamate; ~22 μmol versus ~5 μmol for glycerol; ). Heat-induced hypothalamic hypoxia, ischemia, and damage at 60 minutes were all significantly reduced by pretreatment with honokiol.
Figure 3 showed that the hypothalamic levels of 2,3-DHBA and in the (HSDR + V) rats were significantly higher at 60 minutes after the start of heat exposure than in the (NTDR + V) rats (~180% versus ~100 mmHg for DHBA; ~9.6 μM versus ~2.6 μM for ; ). As shown in this figure, heat-induced increased hypothalamic levels of all these parameters were significantly reduced by honokiol pretreatment in the (HSDR + H) rats.
Figure 4 showed that the hypothalamic values of TUNEL-positive cells in the (HSDR + V) were significantly higher at 60 minutes after the start of heat stress than that in the (NTDR + V) rats (~148 cells versus ~5 cells; ). As shown in this figure, heat-induced increased hypothalamic values of TUNEL-positive cells were significantly reduced by honokiol pretreatment in the (HSDR + H) rats.
Figure 5 showed that the serum values of IL-1β, IL-6, TNF-α, E-selectin, ICAM-1, lactate dehydrogenase, and MPO for (HSDR + V) were significantly higher at 60 minutes after the start of heat stress than that in the (NTDR + V) rats. Heat-induced increased values of these parameters were all significantly reduced by honokiol pretreatment in the (HSDR + H) rats. In addition, serum levels of IL-10 in the (HSDR + H) rats were significantly higher than that in the (HSDR + V) rats at 60 minutes after the start of heat stress.
Table 3 showed that the plasma levels of both ACTH and corticosterone in the (HSDR + V) rats were significantly higher at 60 minutes after the start of heat stress than that in the (NTDR + V) rats. Additionally, (HSDR + H) rats had significantly () higher plasma levels of both ACTH and corticosterone than (HSDR + V) rats.
Table 4 showed that the serum level of BUN, creatinine ALT, AST, and AP in the (HSDR + V) rats were significantly higher at 60 min after the start of heat stress than that in the (NTDR + V) rats. Heat-increased serum levels of BUN, creatinine, ALT, AST, and AP in the (HSDR + V) rats were significantly reduced by honokiol pretreatment in the (HSDR + H) rats.
Severe heat stress induced excessive hyperthermia, splanchnic vasoconstriction, and multiple organ dysfunction or failure. During heatstroke, excessive hyperthermia facilitates the leakage of endotoxin from the intestine to the circulating blood and resulted in leukocytes infiltration and excessive activation of endothelial cells [2, 13]. Tissue ischemia, hypoxia, and damage secreted proinflammatory cytokines which led to excessive production or release of the toxic oxidizing radicals like and DHBA and resulted in multiple organ damage . Amplification of the resultant activated inflammatory state induced accumulation of free radicals and resulted in augmentation of local tissue injury . This systemic inflammation response led to polymorphonuclear cells sequestration in both the lung and liver and resulted in multiple organ dysfunction or failure . In particular, heat-induced multiple organ dysfunction might be associated with hypothalamo-pituitary-adrenocortical (HPA) axis impairment . Their data showed that intolerance to heat exposure was associated with an HPA axis impairment, possibly related to changes occurring in the inflammatory mediators levels.
As mentioned in Section 1, the patients with diabetes were susceptible to heat stroke at Mecca Pilgrimage . Our present study further showed that heat-induced multiple organ dysfunction or failure in streptozotocin-induced diabetic rats was related to tissue inflammation and oxidative stress. Especially, pretreatment with honokiol significantly (a) attenuated hyperthermia, hypotension and hypothalamic ischemia, hypoxia, and neuronal apoptosis, (b) reduced the plasma index of the toxic oxidizing radicals including and 2,3-DHBA, (c) diminished the indices of hepatic and renal dysfunction including creatinine, blood urea nitrogen, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and lactate hydrogenase, (d) attenuated the plasma systemic inflammatory response molecules like soluble intercellular adhesion molecule-1, E-selectin, tumor necrosis factor-alpha, interleukin-1β, and interleukin-6, (e) promoted plasma levels of an anti-inflammatory cytokine, interleukin-10, (f) reduced an index of infiltration of polymorphonuclear neutrophils in the serum as measured by myeloperoxidase activity, (g) enhanced the plasma levels of corticosterone and adrenocorticotrophic hormone, and (h) promoted the survival time fourfold in HSDR. Hence, we suggested that isolating honokiol from Magnolia officinalis might be a potential adjunct in the prevention of heatstroke. In fact, the biological activities of honokiol include potent inhibition of lipid peroxidation [8, 18], scavengers of hydroxyl radicals , inhibition of leukotriene synthesis in leukaemia cells , and inhibition of UV-induced mutations .
Serum molecules like IL-1β, IL-6, TNF-α, ICAM-1, and E-selectin were involved in the pathophysiology of systemic inflammatory response syndromes [22–25]. Activation of both neutrophils and endothelial cells is associated with overproduction of these systemic inflammatory response syndrome molecules in patients  or rats  with heatstroke. In the present study, both hyperthermia and overproduction of these systemic inflammatory response syndrome molecules in rats could be significantly attenuated by honokiol. In addition, honokiol pretreatment facilitated the production of serum IL-10, an anti-inflammatory cytokine,  that occurred during heatstroke. Thus, honokiol might downregulate the extent of activated inflammation via attenuating the heatstroke-induced excessive hyperthermia. The severity of heat illness was believed to depend on the degree of hyperthermia and its duration .
It was promoted that decreased heat tolerance was associated with HPA axis impairment . As shown in the present study, hypothalamic ischemia, hypoxia, and neuronal apoptosis were associated with HPA impairment (evidenced by insufficient release of both ACTH and corticosterone) in HSDR which could be significantly reversed by honokiol. It was likely that honokiol might increase heat tolerance by reducing HPA axis impairment (as reflected by producing more ACTH and corticosterone in plasma in response to heat stress) in rats. The hypothesis is supported by our previous finding showing that glucocorticoids reduced interleukin-1 concentration and resulted in neuroprotective effects in rat heatstroke .
It should be mentioned that the normal rats should release more ACTH and corticosterone in response to heat stress than the normothermic controls (nonetheless, the data are not reported here). However, the plasma levels of both ACTH and corticosterone in heated diabetic rats should be lower than that of heated nondiabetic rats. The reduced release of both ACTH and corticosterone displayed by heated diabetic rats could be reversed by honokiol supplement.
In summary, we demonstrated that honokiol protected against hyperthermia, hypotension, and multiorgan injury in HSDR. The beneficial effects of honokiol might be on the reduction of (a) systemic inflammatory response syndrome molecules like TNF-α, IL-1βIL-6, ICAM-1, MPO, and E-selectin in the plasma, (b) the toxic oxidizing radicals like and 2,3-DHBA, in the plasma, (c) the organ injury indicators like LDH, creatinine, blood urea nitrogen, alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase in the plasma, and (d) an indicator for leukocytes accumulation like MPO in the serum, and thus leading to maintenance of HPA axis function and increased survival in rats with heatstroke-associated multiple organ dysfunction. Our data suggested that honokiol was useful in reducing both inflammation and oxidative stress; lowering heat-induced multiple organ dysfunction.
Conflict of Interests
The authors report no conflict of interests related to this study or the findings specified in this paper.
The results presented in this paper have not been published previously in whole or part, presented in abstract form. All the authors have contributed substantially to the research, preparation and production of the paper and approved its submission to the Journal.
- S. S. Al-Harthi, O. Karrar, S. A. Al-Mashhadani, and A. A. Saddique, “Metabolite and hormonal profiles in heat stroke patients at Mecca Pilgrimage,” Journal of Internal Medicine, vol. 228, no. 4, pp. 343–346, 1990.
- A. Bouchama and J. P. Knochel, “Heat stroke,” The New England Journal of Medicine, vol. 346, no. 25, pp. 1978–1988, 2002.
- S. H. Chen, M. T. Lin, and C. P. Chang, “Ischemic and oxidative damage to the hypothalamus may be responsible for heat stroke,” Current Neuropharmacology, vol. 11, no. 2, pp. 129–140, 2013.
- K. L. Lee, K. C. Niu, M. T. Lin, and C. S. Niu, “Attenuating brain inflammation, ischemia, and oxidative damage by hyperbaric oxygen in diabetic rats after heat stroke,” Journal of the Formosan Medical Association, vol. 112, no. 8, pp. 454–462, 2013.
- J.-P. Wang, T.-F. Ho, L.-C. Chang, and C.-C. Chen, “Anti-inflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice,” Journal of Pharmacy and Pharmacology, vol. 47, no. 10, pp. 857–860, 1995.
- A. M. Clark, F. S. El-Feraly, and W. S. Li, “Antimicrobial activity of phenolic constituents of Magnolia grandiflora L,” Journal of Pharmaceutical Sciences, vol. 70, no. 8, pp. 951–952, 1981.
- K. Y. Ho, C. C. Tsai, C. P. Chen, J. S. Huang, and C. C. Lin, “Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis,” Phytotherapy Research, vol. 15, no. 2, pp. 139–141, 2001.
- Y. Lo, C. Teng, C. Chen, C. Chen, and C. Hong, “Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation,” Biochemical Pharmacology, vol. 47, no. 3, pp. 549–553, 1994.
- G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, Acdemic Press, New Yourk, NY, USA, 1982.
- H. Togashi, K. Mori, K. Ueno et al., “Consecutive evaluation of nitric oxide production after transient cerebral ischemia in the rat hippocampus using in vivo brain microdialysis,” Neuroscience Letters, vol. 240, no. 1, pp. 53–57, 1998.
- C. Yang and M. Lin, “Oxidative stress in rats with heatstroke-induced cerebral ischemia,” Stroke, vol. 33, no. 3, pp. 790–794, 2002.
- K. M. Mullane, R. Kraemer, and B. Smith, “Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium,” Journal of Pharmacological Methods, vol. 14, no. 3, pp. 157–167, 1985.
- D. M. Hall, G. R. Buettner, L. W. Oberley, L. Xu, R. D. Matthes, and C. V. Gisolfi, “Mechanisms of circulatory and intestinal barrier dysfunction during whole body hyperthermia,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 280, no. 2, pp. H509–H521, 2001.
- F. Feihl, B. Waeber, and L. Liaudet, “Is nitric oxide overproduction the target of choice for the management of septic shock?” Pharmacology and Therapeutics, vol. 91, no. 3, pp. 179–213, 2001.
- P. K. Kim and C. S. Deutschman, “Inflammatory responses and mediators,” Surgical Clinics of North America, vol. 80, no. 3, pp. 885–894, 2000.
- R. R. Neviere, G. Cepinskas, W. S. Madorin et al., “LPS pretreatment ameliorates peritonitis-induced myocardial inflammation and dysfunction: role of myocytes,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 277, no. 3, pp. H885–H892, 1999.
- V. Michel, A. Peinnequin, A. Alonso, A. Buguet, R. Cespuglio, and F. Canini, “Decreased heat tolerance is associated with hypothalamo-pituitary-adrenocortical axis impairment,” Neuroscience, vol. 147, no. 2, pp. 522–531, 2007.
- H. Haraguchi, H. Ishikawa, N. Shirataki, and A. Fukuda, “Antiperoxidative activity of neolignans from Magnolia obovata,” Journal of Pharmacy and Pharmacology, vol. 49, no. 2, pp. 209–212, 1997.
- J. Taira, T. Ikemoto, K. Mimura, A. Hagi, A. Murakami, and K. Makino, “Effective inhibition of hydroxyl radicals by hydroxylated biphenyl compounds,” Free Radical Research Communications, vol. 19, supplement 1, pp. S71–S77, 1993.
- Y. Hamasaki, E. Muro, S. Miyanji et al., “Inhibition of leukotriene synthesis by honokiol in rat basophilic leukemia cells,” International Archives of Allergy and Immunology, vol. 110, no. 3, pp. 278–281, 1996.
- S. Fujita and J. Taira, “Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102,” Free Radical Biology and Medicine, vol. 17, no. 3, pp. 273–277, 1994.
- J. A. Morecroft and L. Spitz, “The role of inflammatory mediators in necrotizing enterocolitis,” Seminars in Neonatology, vol. 2, no. 4, pp. 273–280, 1997.
- J. Boldt, M. Wollbruck, D. Kuhn, L. C. Linke, and G. Hempelmann, “Do plasma levels of circulating soluble adhesion molecules differ between surviving and nonsurviving critically ill patients?” Chest, vol. 107, no. 3, pp. 787–792, 1995.
- G. S. Kansas, “Selectins and their ligands: current concepts and controversies,” Blood, vol. 88, no. 9, pp. 3259–3287, 1996.
- K. Goda, T. Tanaka, M. Monden, and M. Miyasaka, “Characterization of an apparently conserved epitope in E- and P-selectin identified by dual-specific monoclonal antibodies,” European Journal of Immunology, vol. 29, no. 5, pp. 1551–1560, 1999.
- W. Liu, C. Chen, N. Foo et al., “Human umbilical cord blood cells protect against hypothalamic apoptosis and systemic inflammation response during heatstroke in rats,” Pediatrics and Neonatology, vol. 50, no. 5, pp. 208–216, 2009.
- T. J. Standiford, R. M. Strieter, N. W. Lukacs, and S. L. Kunkel, “Neutralization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor,” Journal of Immunology, vol. 155, no. 4, pp. 2222–2229, 1995.
- Y. Shapiro, T. Rosenthal, and E. Sohar, “Experimental heatstroke: a model in dogs,” Archives of Internal Medicine, vol. 131, no. 5, pp. 688–692, 1973.
- C. Liu, C. Chien, and M. Lin, “Glucocorticoids reduce interleukin-1β concentration and result in neuroprotective effects in rat heatstroke,” Journal of Physiology, vol. 527, part 2, pp. 333–343, 2000.